Baidu
map
Leuk Res 润色咨询

LEUKEMIA RESEARCH

出版年份:1977 年文章数:2212 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:4.4% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊简介

期刊简介
GetPortalImpactFactorByIdResp(projectId=1, id=2d194589, cover=https://img.medsci.cn/images/journal/cover/2021/Btg_202109271315570590.jpg, fullname=LEUKEMIA RESEARCH, abbr=Leuk Res, pyear=1977, frequence=Monthly, articleNumbers=2212, citedSelf2015=4.4, acceptanceRate=null, submissionToAcceptance=null, averageReviewTime=平均1.8月, reviewFee=null, pageFee=null, publishedRatio=2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%), issn=0145-2126, greenSci=https://www.greensci.net/search?kw=0145-2126, scijournal=https://www.scijournal.org/impact-factor-of-Leuk-Res.shtml, medsciHotlightString=null, medsciHotlightRealtime=5.335, medsciHotlight=7.748, medsciHotlight5year=7.9277, citescore=4.0, hIndex=86, impactFactor=2.7, orgnization=Elsevier Ltd., orgnizationUrl=http://www.elsevier.com, country=United Kingdom, countryCn=英国, isOa=0, isOaString=否, sciScie=Science Citation Index|Science Citation Index Expanded|Current Contents - Life Sciences|BIOSIS Previews, bigclassCas=医学 4区, smallclassCas=医学 4 区, website=https://www.journals.elsevier.com/leukemia-research/, websiteHits=11654, guideForAuthor=, guideForAuthorHits=7, submitWebsite=https://www.editorialmanager.com/lr/tempdown.asp, submitWebsiteHits=3262, content=<p>With a revised editorial board in place, Leukemia Research is further developing its goal of bringing comprehensive and current information to all health care professionals involved in basic research and applied clinical research in both leukemias and other hematologic malignancies. The editors encourage the submission of articles relevant to normal and leukemic hemopoiesis, biochemistry, cell biology, immunology, molecular biology as well as epidemiologic and clinical studies. Specifically, of major interest will be articles that encompass the application of oncogenes, growth factors, cell markers, cell cycle and differentiation agents, novel therapeutics and clinical trials in both the acute and chronic leukemias as well as the myelodysplastic syndromes. In addition we solicit selected articles on the rapidly increasing specialty of marrow or stem cell reconstitution after high dose therapy with curative attempt in patients with a wide range of neoplasms.For more information contact the Myelodysplastic Syndromes Foundation at http://www.mds-foundation.org/</p>, totalCites=5973, brief=Leuk Res杂志医学行业,“<strong><a target="_blank" href="/sci/index.do?smallclass=血液学" >血液学</a></strong>”子行业的偏低级别杂志, articleType=论著为主,其它类型文章约占5-10%, medsciHeat=<span style="color: #000000;">黑</span>, medsciComment=杂志水平一般,也很冷门,关注人少,审稿周期可能也不一定快,如果文章质量不佳,或时间不紧的话,可以考虑考虑。, medsciExplanation=MedSci期刊指数是根据中国科研工作者(含医学临床,基础,生物,化学等学科)对SCI杂志的认知度,熟悉程度,以及投稿的量等众多指标综合评定而成。当然,具体的,您还可以结合“<a href='//m.capotfarm.com/sci/submit.do?id=2d194589'>投稿经验系统</a>”,进行综合判断,这更是大家的实战经验,值得分享和参考。<br> 注意,上述MedSci期刊指数采用MedSci专利技术,由计算机系统自动计算,并给出建议,存在不准确的可能,仅供您投稿选择杂志时参考。, tags=[ImpactFactorTagDto(id=4182, tagName=骨髓瘤, createdHits=1), ImpactFactorTagDto(id=313, tagName=临床, createdHits=1), ImpactFactorTagDto(id=809, tagName=白血病, createdHits=1)], citeScoreList=[GetImpactFactorCiteScoreListResponse(year=2017, citescore=2.17), GetImpactFactorCiteScoreListResponse(year=2018, citescore=2.13), GetImpactFactorCiteScoreListResponse(year=2019, citescore=4.0), GetImpactFactorCiteScoreListResponse(year=2020, citescore=4.7), GetImpactFactorCiteScoreListResponse(year=2023, citescore=4.0)], medsciIndexList=[GetImpactFactorMedsciIndexListResponse(year=2020, medsciHotlight=7.057), GetImpactFactorMedsciIndexListResponse(year=2021, medsciHotlight=6.646), GetImpactFactorMedsciIndexListResponse(year=2022, medsciHotlight=8.726), GetImpactFactorMedsciIndexListResponse(year=2023, medsciHotlight=6.7), GetImpactFactorMedsciIndexListResponse(year=2024, medsciHotlight=5.335)], citeScoreGradeList=[GetImpactFactorCiteScoreGradeResponse(smallClass=Medicine - Hematology , rank=49/122), GetImpactFactorCiteScoreGradeResponse(smallClass=Medicine - Oncology , rank=166/321), GetImpactFactorCiteScoreGradeResponse(smallClass=Biochemistry, Genetics and Molecular Biology - Cancer Research , rank=128/191)], totalJcrAreaList=[GetImpactFactorCiteScoreGradeResponse(smallClass=HEMATOLOGY, rank=Q2), GetImpactFactorCiteScoreGradeResponse(smallClass=ONCOLOGY, rank=Q3)], pmcUrl=https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0145-2126[ISSN], pubmedUrl=https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=LEUKEMIA RESEARCH[ta], article_number=126, article_number_cn=17, earlyWarning=null, linkOutUrl=null, isJournalMember=false, unscrambleContent=null, dayViewCount=false, endexampletyle=暂无数据)
期刊名称
Leuk Res/LEUKEMIA RESEARCH
ISSN
0145-2126
影响指数话题
预警等级
MedSci期刊指数
5.335 (MedSci实时期刊指数) | 7.9277 (5年期刊指数)
CiteScore值
4.0
h-index
86
h5-median
暂无数据
出版社/管理机构
杂志由 Elsevier Ltd. 出版或管理
出版国家/地区
United Kingdom 英国
出版周期
Monthly
出版年份
1977
是否OA
被收录情况
Science Citation Index|Science Citation Index Expanded|Current Contents - Life Sciences|BIOSIS Previews
JCR分区
HEMATOLOGY Q2
ONCOLOGY Q3
中科院分区
大类:医学 4区
小类:医学 4 区
Baidu
map
Baidu
map
Baidu
map